Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2007-11-26

Original market date: See footnote 1

1985-12-31

Product name:

SUFENTA INJ 50MCG/ML

DIN:

01951319 Electronic product monograph is not available

Company:

JANSSEN INC
19 Green Belt Drive
Toronto
Ontario
Canada M3C 1L9

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Epidural ,  Intravenous

Number of active ingredient(s):

1

Schedule(s):

Narcotic (CDSA I)

 

American Hospital Formulary Service (AHFS): See footnote 3

28:08.08 

Anatomical Therapeutic Chemical (ATC): See footnote 4

N01AH03 SUFENTANIL

Active ingredient group (AIG) number:See footnote5

0144821001

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
SUFENTANIL (SUFENTANIL CITRATE) 50 MCG / ML
Version 4.0.3

"Page details"

Date modified: